Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact

Search

Close

Enter Search Terms

Brian R. Daley

Brian R. Daley

ID: 1b834fdf-2619-30fb-68c4

/

Claimed Record

/

Organization: Norton Rose Fulbright

Federal Court of Appeal Gradually Phases Out Suspension Period

Pharma in Brief · June 22, 2021

Modifications aux Règles des Cours fédérales : introduction de la proportionnalité et modification de la procédure des requêtes devant la Cour d’appel fédérale

Les Actifs créatifs · April 26, 2021

Federal Court of Appeal Restores Suspension Period

Pharma in Brief · April 26, 2021

PMPRB Update: New periods for compliance with the new Guidelines

Pharma in Brief · April 20, 2021

Arbitrage des différends en propriété intellectuelle dans le secteur des produits pharmaceutiques, des sciences de la vie et des soins de santé en période de pandémie de COVID-19

Les Actifs créatifs · March 16, 2021

Previous

1 2 345...13

Next

Practice Areas

Health Care and Life Sciences

Intellectual Property

Jurisdictions

Publishing Record

Publisher Since 2015

Total Articles 63

Most Recent September 19, 2024

Cite This Author

Brian R. Daley, Norton Rose Fulbright

LexBlog Author ID:

1b834fdf-2619-30fb-68c4

www.lexblog.com/author/briandaley

Contact

FirmNorton Rose Fulbright

Emailbrian.daley@nortonrosefulbright.com

BlogsHealth Law Pulse

Les Actifs créatifs

Pharma in Brief

The Brand Protection Blog

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Library at LexBlog
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog